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ABSTRACT 
 
Aberrant DNA methylation in the genome is associated with human cancers. Tumor cells 
can undergo an overall loss of DNA methylation in non-coding repetitive regions 
(including the Alu elements) and at the same time maintain hypermethylation in the CpG 
islands in promoter region of multiple genes. We are interested in understanding the 
pattern of DNA methylation in the promoters of genes that may mediate the tumor 
genesis in colon cells.   Recent literature survey suggested that about two dozens of 
genes, when mutated or undergone changes in DNA methylation, can directly promote 
the development of colon cancers. We downloaded the promoter sequences of these 
possible colon cancer causing genes from the Human Genome Browser for 
bioinformatics analysis and investigation of the sequence features on their Alu elements, 
transcription factor binding sites, and CpG islands.  Our results suggest that sequence 
conservation of the flanking transcription factor binding sites plays an important role in 
protecting their flanking CpG islands from hypermethylation.  In addition, colon cancer 
genes may harbor a lower density Alu element when compared to control random genes.  
We selected 4 characteristics of DNA sequences for machine learning and prediction of 
colon cancer genes.  
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CHAPTER ONE 
LITERATURE REVIEW 
 
Introduction 
 
Cancer results from an accumulation of genetic changes within a cell that allow 
uncontrolled cell growth.  Not associated with DNA sequences change, DNA methylation 
represents an epigenetic means of inheritance.  Cytosine methylation is the most common 
epigenetic modification of DNA in human cells.  In humans, within tandem and 
interspersed repeats in CpG rich region, lies most of the methylated cytosines.  Alu 
elements are the most common repeat sequence family.  Demethylation of Alu occurs 
often in aging and cancer development [1].  It is thought that the frequent 
hypomethylation of repetitive elements is responsible for the global hypomethylation 
seen in diverse human cancers [2].  CpG islands mostly locate in promoter region of the 
genes, and are hypermethylated in human cancers [9]. 
 
Alu subfamilies’ distribution in colon cancer genes 
 
The term “repetitive element” refers to DNA sequence, with multiple copies of the same 
repetitive nucleotides present in the genome.  Repetitive elements are categorized into 
two groups.  One group is tandemly arrayed sequence such as microsatellites, 
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minisatellites, and telomeres.  The other group is interspersed sequence such as mobile 
element and pseudo genes.  Interspersed sequence could be divided on the basis of size. 
SINE (short Interspersed element) belongs to interspersed sequence, and is less than 500 
bp long [3].   Alu SINEs were identified almost 30 years ago [4].  The Alu sequence was 
so named because it contains a recognition site for the restriction enzyme AluI [4].   
 
A series of Alu subfamilies of different ages have evolved from the propagation of Alu 
elements to more than one million copies during the past 65 million years.  Each Alu 
element consists of a ~300 base pair long sequence, with 5’ half (containing an RNA 
polymerase III promoter) and 3’ terminus (containing a stretch of As which sometimes 
interspersed with C, G or Ts) [3].  
 
It is thought that a processed 7SL RNA provides the ancestral element named “FAM” 
(fossil Alu monomer) for Alu element [19].  FAM later evolved into two sequence 
variants named FLA (free left Alu monomer) and FRA (free right Alu monomer).  With 
the fusion of an FRA and an FLA, the progenitor of the Alu family appears (Figure 1.1). 
During the fusion, the FLA remains its internal RNA polymerase III promoter.  Each Alu 
element monomers are separated by a stretch A region with its 3’ terminus a poly-A tail 
[19]. 
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Figure1.1: The origin of Alu elements (adopted from [19]).  Alu element originates from 
a processed 7SL RNA, which evolved to FAM.  FLA and FRA are two variants of FAM.  
FLA and FRA fuse to form Alu sequences. 
 
Alu element amplification is believed to be a result of retrotransposition.  The process 
includes: (1) producing transcripts of RNA polymerase III in Alu and (2) reverse 
transcription of the transcripts.  In order for amplification to exist, Alu element needs to 
“borrow” the factors which are necessary in amplification since Alu element does not 
have open reading frames.  Usually Alu element borrows such factors from long 
interspersed elements (LINEs) [6].  
 
Only a very few human Alu elements have the ability of retrotransposition, so they are 
called source genes or “master” [7] genes.  Because it lacks the appropriate flanking 
sequences, the internal RNA polymerase III promoter in Alu copies does not transcribe 
actively in vivo [8].  As a result, usually new Alu copies in human genome are not 
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functional in retrotransposition, except when they happened to land in a region where the 
active ability to the incomplete RNA polymerase III promoter is provided.  Even when 
Alu copies are transposed in the “lucky” region, they also have a short life.  There are 
two possible reasons for this: (1) individual Alu copy contains more than 24 CpG 
dinucleotides, which are easy to mutate because of the deamination of 5methy-cytosine 
residue[10].  The fact that mutations often occurred in the CpG dinucleotide leads to 
elimination of the new Alu element’s retrotransposition ability, (2) a defect in A-rich tail 
of Alu element could also contribute to the failing of the retrotransposition of the new 
Alu element.  This is because after a new Alu element integrates into a new region, the 
stretch-A tail of individual Alu copy (which has been proven important in the 
amplification process) may also easily become mutated and change to simple sequence 
[14-16].  In summary, it is very hard for individual Alu copy to expand the copy number 
of Alu element [7]. 
 
Only in the “master” gene, the accumulating mutations are passed on to their copies.  
Hence, characterized through a series of hierarchical mutations, several distinct Alu 
subfamilies, on different genetic age, comprise the human Alu element family.  There are 
three major Alu subfamilies: AluY, AluJ and AluS.  Under each major Alu subfamily, 
there exist small subfamilies (Figure 1.2).   
 
 5
 
Figure 1.2: Alu elements expansion in primates (adopted from [3]). There are mainly 
three major Alu subfamilies: AluY, AluS, AluJ.  Each Alu subfamily is colored according 
to the times of amplification peak.  Dark purple: AluJ, light blue: AluS, light purple: 
AluY.  Each Alu subfamily’s copy number is also listed according to the time. 
 
Among different Alu sequences, there are commonly high proportions of correlated base 
occurrences in some certain positions. This can be used to separate Alu element into 
different Alu subfamilies [5].  The fact that many human Alu elements share common 
diagnostic sequences has been proven in some laboratories [64].  In addition, different 
Alu subfamily also contains different consensus  sequence (Figure 1.3).  
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Figure 1.3.  Consensus sequence in the alignment of Alu subfamilies [64].  The 
consensus sequence for Alu small subfamily Alusx is shown at the top. The younger Alu 
subfamily is progressively underneath the Alusx sequence.  Dot refers to the same base as 
it is in the consensus sequence.  Dash refers to deletion comparing to the consensus 
sequence.  Colored box refers to mutation.  The newer subfamily (such as Ya5) not only 
has all the mutations that belong to the ancestral Alu element, but also has several extra 
mutations which are the diagnostic positions for the particular Alu subfamily.  
 
Previous studies showed that there is an inverse relationship among Alu families based 
on the age of the Alu family and its methylation status.  The younger Alu family usually 
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exhibits higher methylation rates, compared to the older Alu family, which implies that 
there is a stronger silencing pressure put on the younger Alu elements [18].   
 
Alu element acts as de novo methylation center 
 
It has been suggested that the high level of methylation of Alu elements inhibit gene 
transcription [20, 21].  It is also suspected that Alu elements might induce de novo 
methylation.  SINEs genomic region were found in some cases to induce de novo 
methylation of the genomic sequences nearby [32].  In neoplasia, tumor suppressor 
genes, such as TP53 gene [23, 24] play an important role in tumor genesis.  Alu human 
sequences were believed to be the potential de novo methylation centers in these tumor 
suppressor genes [32]. 
 
Depending on the distance between nearest Alu element to the transcription start site in 
human genome, there is a linear or inverse correlation between the size of CpG island and 
density of the Alu elements [17].  If the distance between the transcription start site and 
nearest Alu element is less than 2000 base pairs, the longer the CpG island, the lower 
density the Alu element has; if the distance between transcription start site and nearest 
Alu element is longer than 2000 base pairs, the longer the CpG island, the higher density 
the Alu element has [17].  There also is a linear relationship between CpG island length 
and the distance from the transcription start site to the nearest retroelements [17].  A 
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transitional area is located between retro-elements and the CpG island.  Methylation can 
be expended from retro-element to the CpG island through transitional area (Figure 1.4).  
 
 
Figure 1.4. Methylation is extended from retrotransposons to transitional area and CpG 
islands near transcription start site [17].  The extent of the methylation spreading could be 
predicted by the length of the CpG island.  The longer the CpG island, the further away  
the retroelement is from the transcription start site. 
 
CpG island protection model 
 
CpG islands in the promoter regions are the only regions in genome where the frequency 
of CpG dinucleotides is close to the expectations [17].  In other regions, the frequency of 
CpG dinucleotides is much lower than in CpG islands.  CpG islands contain several 
characteristics [17]: (1) A sequence at least 200 base pair long, (2). A GC percentage 
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greater than 50%, (3) Observed/expected CpG ratio greater than 60%.  Most CpG islands 
are usually located very near to the transcription start site of housekeeping genes in 
mammals.  One possible mechanism for silencing tumor suppressor genes in cancer cells 
is the aberrant hypermethylation of CpG islands in the promoter regions of these tumor 
suppressor genes [25].  DNA methylation, an epigenetic modification, gives rise to the 5-
methylated cytosine by adding a methyl-group to the fifth carbon of the cytosine.  In 
normal cells, CpG dinucleotide in CpG islands usually is unmethylated in the promoter 
region, but methylated in coding region of the gene.   
 
It has been proposed that Sp1 transcription factor binding sites can behave as the 
boundaries which could prevent the CpG islands from methylation from these 
methylation centers [31].  Subsequently, the methylated CpG dinucelotides could not 
diffuse their methylation to the unmethylated nearby CpG dinucleotides [29].  Tumor 
genesis could be stopped by the Sp1 protection to the CpG dinucleotide in the promoter 
region from methylation (Figure 1.5).  
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Figure 1.5. Sp1 protection model (adopted from [31]).  Alu elements are “de novo 
methylation centers” which pass its methylation to the nearby CpG islands.  Sp1 
transcription factor binding sites flank the CpG island, protecting it from the expanded 
methylation from the methylation centers.  In this diagram, grey circles refer to the 
unmethylated cytosines, red circles refer to the methylated cytosines. 
 
The Sp1 transcription factor binding sites are not present in the promoter region of all 
cancer-related genes, so it is reasonable to predict that other transcription factor binding 
site consensus sequence which flanks the CpG island in promoter region could also 
behave as boundaries to protect the CpG island from methylation from the nearby 
methylation centers (Figure 1.6).  In the experiment on T24 bladder carcinoma cell line, 
after demethylation was achieved by adding 5-aza 20-deoxycytidine, the time for 
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remethylation is prolonged, which proves the protective effect on the CpG island by the 
flanking of the transcription factor binding sites [30].  In this T24 bladder carcinoma cell 
line experiment, after demethylation, the remethylation of p16 exon 2 CpG island is more 
rapidly than the p16 promoter CpG island, Sp1 sites within the CpG island in p16 
promoter region is thought to play an important role in protecting the CpG island from de 
novo methylation. 
  
 
 
Figure 1.6: A protection model for gene MAL.  Squares refer to the two CpG islands 
found in the promoter region of the MAL gene.  The paired circles refer to two pairs of 
transcription factor binding sites which flank the CpG island within 50 base pairs, 
protecting the CpG island from methylation.  One pair of transcription factor binding 
sites is COMP, the other pair of transcription factor binding sites is MOK2. 
 
 
50 bp 50 bp 50 bp 50 bp 
900 1000 1500 1600 800 1700 
COMP1 MOK2 COMP1 MOK2 
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CpG and TpG dinucleotides density 
 
A guanine following a cytosine is not common in vertebrate DNA sequence.  During 
evolution, through deamination, the methylated cytosine is transformed into thymine, and 
the unmethylated cytosine changed into uracil.  Subsequently, the DNA repair 
mechanism treats uracil as extraneous base in DNA and substitute it, because uracil only 
occurs in RNA.  5-methylated cytosine (5-meC) deamination produces thymine (T), 
which creates C.G to T.A transition. CpG becomes TpG. This transition will remain in 
the DNA sequence without the recognition and repair by the repair enzyme.  Since the 
transition C->T creates “damage” T which still belongs to a normal DNA base, it requests 
higher level recognition by the repair enzyme [33, 43].  
 
 
 
 
 
 
 
 
 
 
 
 13
CHAPTER 2 
METHODS AND DATA 
 
Data 
 
Experimental evidence shows that hypermethylation of the CpG island in the promoter 
region of multiple genes is closely associated with colon cancer happening [34-39].  We 
have selected 24 colon cancer genes from literature: TAC1, TBXA2R, PTGS2, MLH1, 
FAT, SFRP1, ENG, DKK1, CALCA, RBP1, STK11, GATA5, AKAP12, EPHB2, 
GATA4, LMX1B, TMEFF2, CDKN2A, WIF1, SST, WRN, NELL1, MAL, RARB 
(Appendix table 1), we will call these ‘colon cancer genes’ in this study.  
 
We also selected 166 genes with hypermethylated promoters that are associated with 
colorectal cancer [40].  These 166 colorectal cancer genes will be used as independent 
controls to investigate the difference between colon cancer related genes and normal 
genes.  We will call these ‘colon cancer related genes’ in this study. 
 
For normal, non-cancer genes, 90 genes in chromosome 21 were obtained from the study 
by Yamada and co-workers [41].  75 genes with unmethylated promoter, 15 genes with 
methylated promoter.  The genomic DNA in the experiment was received from human 
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peripheral blood leukocytes and placental tissue.  In current study, promoter sequences 
will be called ‘Yamada methylated genes’ and ‘Yamada unmethylated genes’. 
 
Weber and co-workers studied the methylation ratio of about 16,000 promoters in 
fibroblast cells [42].  23 out of 24 of our colon cancer genes could be found in Weber 
study.  As a negative control, based on the respective methylation ratio of the 
hypermethylated 23 colon cancer genes, we randomly selected 50 genes which contain 
the similar methylation ratio as the 23 colon cancer genes from Weber’s data.   In 
addition, 48 random genes with hypermethylation in their promoters from the Weber data 
were also selected for evaluation of the performance of the classifiers in machine learning 
during the later stage of this study. 
 
Finally, as part of the performance evaluation for classifiers in machine learning, we 
selected 147 genes that are labeled as colon cancer related genes in NCI cancer gene 
database [69]. 
 
In total, five groups of data were used for this study: (1) 24 colon cancer genes (2) 166 
hypermethylated ‘colon cancer related genes’. (3) 75 Yamada unmethylated genes (4) 15 
Yamada methylated genes (5) 50 control random genes.  
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Methods 
 
Alu sequence prediction and assembly 
 
Our operational definition of promoter region is the genomic DNA sequence 2000 bp 
upstream of the transcription start site (TSS) of a gene.  Promoter sequences upstream the 
transcription start sites are downloaded from Ensembl Biomart genome browser [65]. 
 
Alu element prediction was performed by the on-line software “Censor” [44, 66], using 
option of masking “N” symbols, and reporting the classification of the repetitive 
sequences.  The data assembly was achieved by Perl programming. 
 
Transcription factor binding site prediction 
 
From a computational biology view, transcription factor binding sites (TFBSs) can be 
represented by position weight matrices PWM [47], which describe the TFBS by giving 
the complete nucleotide distribution for each single position in the TFBS.  We use the 
software MatInspector [46, 68] for TFBS prediction.  MatInspector, based on a large 
database of matrix for different transcription factor binding sites, locates matches in the 
query DNA sequences and assigns percentage of similarity to matches to evaluate the 
matches. 
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CpG island prediction and assembly 
 
CpG island prediction was achieved through CpGPlot predictor [45, 67].  The criteria for 
CpG islands were: length longer than 50 bp, GC content larger than 50% and CpG 
Expected/Observed ratio greater than 60%.  
 
Classification, Feature selection, Prediction and Gene Ontology 
 
Classification 
 
The procedure for classification is usually based on a number of characteristics. The 
training procedure is to find a decision rule which could explain the data set well.  
 
Because we didn’t have a large collection of data (i.e. we have only 24 colon genes), as in 
most biological studies, using independent data for test set is impractical.  One common 
technique to partially increase the robustness of the classification is to use the method of 
cross validation [50]. 
 
Cross-validation is a statistical practice which partition a data sample into subsets, then 
the analysis is initially performed on a single subset, the other subsets are kept for 
subsequent practice in volition of the initial analysis. We used the method of 10 folds 
cross-validation in which the original data sample is partitioned into 10 sub-samples. One 
 17
sub-sample is kept as validation data for testing the model, called testing set, the 
remaining nine sub-samples are used as training data.  The process of cross-validation is 
repeated ten times (10 folds), each of the 10 sub-sample is used once as the testing set. 
Then the ten results are averaged to create the final estimation [50]. 
 
We have used two classifiers and compared the performance of the two methods. 
 
Classifier I: Naïve Bayes 
 
The Naïve Bayes classification is based on Bayes theorem.  Naïve Bayes method 
combines the probability of each feature on the class label, assuming the independence 
between the features, calculates the probability of correctness of hypothesis.  For 
example, the Naïve Bayes classifier will hypothesize that: X1, X2 are cancer genes, then 
it calculates all the probabilities and chooses the highest probability [59].  
  
Classifier II: Decision tree 
 
A decision tree is the algorithm which takes the input situation by a list of attributes, and 
produces a yes/no decision, displaying graphically the relationships underlying the data.  
Decision tree works by recursively partitioning the training set until each partition is 
composed of examples entirely from one class.  Non-leaf nodes in the tree represent a 
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splitting point which determines how the data is partitioned.  The partition proceeds until 
inside each partition all the instances belong to the same class [60].  
 
We used the software Weka (Waikato Environment for Knowledge Analysis) [49] for 
implementation of Naïve Bayes and Decision Tree classifiers.  We used the programs 
NaiveBayes for Naïve Bayes and J48 for decision tree, respectively, in WEKA.  
 
Feature selection 
 
Feature selection could help improve the performance of the classification model by 
getting rid of some unnecessary redundant features.  It is usually achieved by building 
classification models by choosing some more important features out of a list of features.  
 
Gene Ontology 
 
The Gene Ontology [22] is a controlled biological vocabularies (i.e. ontologies) that 
describe gene products based on their functionalities in the cell.  In order to obtain more 
insights, we use gene ontology (GO) to annotate the gene list and separate the predicted 
colon cancer gene candidates from the non-colon cancer gene candidates.  We used the 
on-line software “FatiGO” [64, 70] for GO annotation.  
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CHAPTER 3 
ALU ELEMENT STUDY 
 
Alu subfamily distribution is significantly different between colon cancer 
and other normal genes 
 
Our results suggest that in the 24 colon cancer genes, AluS, AluJ and AluY subfamilies 
all occurred, and the Alu subfamily distribution proportion is similar to Yamada 
unmethylated genes (Figure 3.1).  In Yamada methylated genes, AluY subfamily is 
absent for every single gene, but enriched with AluS subfamily (88% of genes).  In 
random genes, Alu distribution is different from other groups of genes.  They contain all 
the three major Alu subfamilies with the AluS subfamily having the highest proportion 
(Figure 3.1).  
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Figure 3.1: Alu family members’ distribution.  The average proportion of each Alu 
subfamily in each group is calculated by the value: (number of Alu element belonging to 
one subfamily) / (total number of Alu elements).   
 
For the average number of Alu element per gene, there is no significant difference 
between colon cancer genes and any other group of genes (Figure 3.5). 
 
The average number of AluY subfamily per gene in colon cancer genes is the lowest 
compared to Yamada unmethylated (P <0.05), colon-related (P <0.05) and Yamada 
methylated genes (P <0.01) (results from a parewise t-test, respectively).  The difference 
in AluY subfamily distribution between colon cancer genes and Yamada methylated 
genes is the largest (Figure 3.2).  For the average number of AluJ subfamily, there is a 
significant difference between colon cancer genes and Yamada methylated genes, 
between colon cancer genes and colon cancer related genes (Figure 3.3).  The average 
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number of AluJ subfamily per gene in colon cancer genes is as low as Yamada 
methylated genes, both being lower than other groups of genes (Figure 3.3).  For AluS 
subfamily, there is a significant difference between colon cancer genes and Yamada 
unmethylated genes, between colon cancer genes and colon cancer related genes (Figure 
3.4).  The average number of AluS subfamily per gene in colon cancer is lower than in 
other groups (Figure 3.4). 
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Figure 3.2: Average number of AluY elements.  The average number of AluY element 
per gene in each group is calculated by the value: (total number of AluY elements) / (total 
number of genes containing AluY elements).  Pairwise t-tests were performed between 
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colon cancer genes and each of the other four groups of genes.  * denotes P < 0.05; ** 
denotes P < 0.01.  
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Figure 3.3: Average number of AluJ elements.  The average number of AluJ element per 
gene in each group is calculated by the value: (total number of AluJ elements) / (total 
number of genes containing AluJ elements).  Pairwise t-tests were performed between 
colon cancer genes and each of the other four groups of genes.  * denotes P < 0.05.  
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Figure 3.4: Average number of AluS elements.  The average number of AluS element per 
gene in each group is calculated by the value: (total number of AluS elements) / (total 
number of genes containing AluS elements).  Pairwise t-tests were performed between 
colon cancer genes and each of the other four groups of genes.  * denotes P < 0.05.  
 
Colon cancer genes harbor a lower density Alu element close to transcription 
start site 
 
Our results suggest that each group of genes has more than 50% genes that do not contain 
any Alu element (Table 3.1).  Colon cancer genes contain the lowest proportion of genes 
containing Alu elements and also have the lowest Alu density among all of the five 
* *
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groups of genes.  Statistical test results, however, do not support the difference in Alu 
element density being significant (pairwise t-tests, data not shown); possibly due to the 
large standard deviation in each group (Figure 3.5). 
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Figure 3.5:  Average number of Alu elements.  The average number of Alu element per 
gene in each group is calculated by the value: (total number of Alu elements) / (total 
number of genes containing all Alu elements).  Pairwise t-tests were performed between 
colon cancer genes and each of the other four groups of genes. 
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Table 3.1: Percent of genes contains Alu element in each group. 
 
 
Our results indicate that the distance from the nearest Alu element to the transcription 
start site in colon cancer genes in average is shorter than that in other groups of genes.  
Again, possibly due to the large standard deviation in each group, the difference in 
distance was not significant (pairwise t-tests, data not shown), (Figure 3.6). 
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Figure 3.6: Average distance between the nearest Alu element to transcription start site 
per gene.  Average distance between the nearest Alu element and transcription start site 
in colon cancer is the lowest.  This diagram is based only on the genes containing Alu 
elements.  T-test is done between colon cancer genes and each of the other four groups of 
genes.  T-test shows there is no significant difference between colon cancer genes and 
other groups of genes. 
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CHAPTER 4 
CpG ISLAND METHYLATION STUDY 
 
Sp1 protection model 
 
22 out of 24 colon genes contain predicted CpG islands (Table 4.1).  18 out of these 22 
colon cancer genes have paired TF flanking CpG island within a 50bp range (Table4.2), 
with average transcription factor binding sites number per gene of 3.6.  
 
Table 4.1 Percent of genes contains CpG islands in each group. 
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Table 4.2: Percent of genes contains paired TFBS flanking CpG island within 50bp in 
each group. 
 
 
The proportion of genes containing paired TFBS flanking CpG island within 50 base 
pairs in colon cancer genes is the highest, 0.75, and that in Yamada methylated genes is 
the lowest.  However, for the density of paired TFBS flanking CpG island in the genes 
which contains them in each group, colon cancer genes have the lowest number, while 
Yamada unmethylated genes have the highest number.  However, these differences were 
not sufficient to be statistically significant (pairwise t-test, results not shown) (Figure 
4.1).  
 
 29
0
1
2
3
4
5
6
7
8
9
10
11
12
13
Colon cancer Colon cancer
Related
Yamada
UnMethy lation
Yamada
Methy lation
Random
A
ve
ra
ge
 N
um
be
r o
f P
ai
re
d 
TF
BS
 p
er
 G
en
e
 
Figure 4.1:  Comparison of average number of paired TFBS flanking CpG island within 
50 bp per gene among different groups.  The average number of paired TFBS flanking 
the CpG island within 50bp per gene in each group is calculated by the value: (total 
number of paired TFBS flanking CpG island within 50bp for all the genes) / (total 
number of genes containing paired TFBS flanking CpG island within 50bp). Pairwise t-
tests were performed between colon cancer genes and each of the other four groups of 
genes. 
 
We hypothesize that TFBS sequence conservation could play a role in protection of CpG 
islands against the methylation originated from Alu elements: when the degree of 
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matched sequence of TFBS is low with respect to the consensus, the binding of 
transcription factor (TF) will be weak and thus could not prevent the spreading of 
methylation into the nearby CpG islands.  To test this hypothesis, we calculated the 
sequence conservation of the flanking TFBS.  Our results suggest that the average 
sequence conservation of the TFBS flanking the CpG islands in colon cancer genes and 
Yamada methylated genes are lower than other groups of genes (Figure 4.2).    
 
There is a significant difference in the sequence conservation between colon cancer genes 
and Yamada unmethylated genes, also between colon cancer genes and random genes 
(Figure 4.2).  
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Figure 4.2:  Comparison of sequence conservation of paired TFBS flanking CpG islands.  
Pairwise t-tests were performed between colon cancer genes and each of the other four 
groups of genes.  * denotes P < 0.05, ** denotes P < 0.01. 
 
CpG island density is related to colon cancer 
 
Our results indicate that the proportion of genes containing CpG islands in colon cancer 
gene group is higher than other groups of genes except for Yamada methylated genes.  
However, the average density of CpG islands per gene in colon cancer groups is lower 
than in other groups. (Figure4.3). However, no significant difference can be demonstrated 
by statistical means ((pairwise t-test, results not shown). 
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Figure 4.3: Number of CpG islands among different groups of genes. This diagram is 
based only on the genes containing CpG islands.  The average number of CpG island per 
gene is calculated by the value: (total number of CpG islands for all the genes) / (total 
number genes containing CpG island).  
 
CpG dinucleotide and TpG dinucleotide 
 
CpG dinucleotides in CpG island in promoter region are the main targets for enzyme 
transferases involved in DNA methylation [31].  We thus inspected the average percent 
of CpG dinucleotide in CpG islands for each group. Our findings suggest that the CpG 
dinucleotide in CpG islands in colon cancer is indeed slightly higher than in other groups 
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of genes (P<0.05 in pairwise t-test between colon cancer genes and random genes) 
(Figure 4.4). 
 
Throughout evolution, methylated CpG could become TpG because of deamination [33]. 
Our results suggest that the average percent of TpG dinucleotide in CpG islands in colon 
cancer genes and colon cancer related genes and random genes is lower than other groups 
of genes, although these differences are not statistically significant (data not shown) 
(Figure 4.5).  We reasoned that the dinucleotide environment in the entire promoter 
region may play a role in determining the methylation in cancer genes.  When we 
inspected promoter region in colon cancer genes in comparison with other groups of 
genes, the results showed that  the average percent of CpG dinucleotide in promoter 
region in colon cancer genes is the highest among all of the five groups of genes (P 
values <0.05 Figure 4.6).  On the other hand, the average TpG dinucleotide percent in 
promoter region in colon cancer genes is the lowest among all the five groups of genes 
(p-values < 0.05, Figure 4.7). 
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Figure 4.4: Comparison of average CpG dinucleotide percent in the CpG island (CGI) per 
gene.  This diagram is only based on the CpG island region of the genes containing CpG 
islands.  The average dinucleotide CpG per gene is calculated by the value:  (total number 
of dinucleotide CpG) / (number of all possible dinucleotides). * denotes P < 0.05 
(pairwise t-test) 
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Figure 4.5: TpG dinucleotide in CpG islands among different groups of genes. This 
diagram is only based on the CpG island region of the genes containing CpG islands. The 
average dinucleotide TpG per gene was calculated by the value: (total number of 
dinucleotide TpG) / (number of all possible dinucleotides).  
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Figure 4.6:  Comparison of the average dinucleotide CpG percent for the entire promoter 
region.  This diagram is based on the whole promoter region.  The average dinucleotide 
CpG percent per gene is calculated by the value: (number of dinucleotide CpG) / (number 
of all possible dinucleotide).  * denotes P < 0.05 (pairwise t-test). 
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Figure 4.7:  Comparison of the dinucleotide TpG percent in entire promoter region per 
gene. This diagram is based on the whole promoter region. The average dinucleotide TpG 
percent per gene is calculated by the value: (number of dinucleotide TpG) / (number of 
all possible dinucleotides). 
 
G+C content is different between colon cancer genes and normal genes 
 
To determine whether G+C content can be used to distinguish colon cancer genes from 
other groups of genes, we compute the percentage of G+C in the CpG islands for each 
gene group (Figure 4.8).  Our results suggest that the average GC content in random 
genes is the lowest and there is a significant difference only between colon cancer genes 
and random genes (P< 0.05, pairwise t-test).  
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Figure 4.8:  Comparison of average G+C content percent in promoter.  The average GC 
content percent per gene is calculated by the value:  (number of nucleotide G + number of 
nucleotide C) / (total number of nucleotides in promoter.).  * denotes P < 0.05 (pairwise 
t-test). 
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CHAPTER 5 
FEATURE SELECTION, CLASSIFICATION, PREDICTION 
AND GENE ONTOLOGY 
 
In total, we have studied the following 11 features for comparison between colon cancer 
genes and four other groups of genes: (1) average number of Alu elements per gene; (2) 
average number of AluY subfamily elements per gene; (3) average number of AluJ 
subfamily elements per gene; (4) average number of AluS subfamily element per gene; 
(5) average distance from the nearest Alu element to TSS per gene; (6) average number 
of CpG island per gene; (7) average number of paired TFBS flanking CpG island within 
50bp per gene; (8) average sequence conservation for paired TFBS flanking CpG island 
within 50bp per gene; (9) average percent of TpG dinucleotide in promoter region per 
gene; (10) average percent of CpG dinucleotide in promoter region per gene; (11) 
average percent of GC content in promoter region per gene (Figure 5.1).  
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Figure 5.1: Significant difference distribution of 11 features.  The black or gray box 
depicts the difference between colon cancer genes and the genes in the group.  Four gray 
boxes denote four features in which significant difference between colon cancer genes 
and the random genes exist. 
 
Feature selection and classification 
 
Based on the statistical result, four features are used to train the classifiers for separation 
of colon cancer genes from random genes: (1). average sequence conservation for paired 
TFBS Flanking CpG island within 50bp per gene, (2). average percent of TpG 
dinucleotide in promoter region per gene, (3). average percent of CpG dinucleotide in 
promoter region per gene, (4). average percent of GC content in promoter region per 
gene.  The training set used 24 colon cancer genes and 24 random genes. 10 folds cross-
validation is used to improve the robustness of the classifiers.  For 24 colon cancer genes, 
Naïve Bayes classifier correctly classified 17 instances, incorrectly classified 7 instances; 
in comparison, the decision tree method J48 correctly classified 21 instances, incorrectly 
classified 3 instances.  For 24 random cancer genes, Naïve bayes classifier correctly 
classified 24 of 24 instances, and incorrectly classified 0 instances; Decision Tree 
classifier correctly classified 20 instances, incorrectly classified 4 instances (Table 5.1). 
To sum up, Naïve Bayes performs well in the random gene set while the decision tree 
method predicts similar number of correct cases for both colon cancer genes and random 
genes. 
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Table 5.1: Comparison between two classifiers on 24 colon cancer genes and 24 random 
genes.   
 
 
Prediction 
 
It is of great interest to apply classifiers to unknown genes and provide basis for future 
experimental verification. To this end, we selected an independent set of 48 random 
genes from the study by Weber and co-workers [42] and 147 NCI colon cancer related 
genes [69].  NCI cancer gene database is composed of 1500 experimental identified 
cancer genes.  The 147 NCI colon cancer related genes were obtained through National 
Center Institute cancer database by searching the key word ‘colon cancer’.  
 
For 48 random genes, the Naïve Bayes method predicted 2 colon cancer genes (4%) and 
46 non-colon cancer genes (96%).  The decision tree method predicted 9 colon cancer 
genes (18%) and 39 non-colon cancer genes (39).  For 147 NCI colon cancer related 
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genes, the Naïve Bayes method predicted 4 colon cancer genes (8%) and 44 non-colon 
cancer genes (92%).  The decision tree method predicted 18 colon cancer genes (38%) 
and 30 non-colon cancer genes (62%) (Table 5.2).  
 
Table 5.2: Comparison between two prediction methods on 48 random genes and 147 
NCI colon cancer related genes.  
 
 
The predicted colon cancer genes from each of the two groups of genes are listed in Table 
5.3.  We hypothesized that the genes which were predicted by both classifiers have a high 
probability of being true colon cancer genes based on the four features.  The common 
predicted colon cancer genes by both Naïve Bayes and Decision tree are listed in Table 
5.4. and Table 5.5 
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Table 5.3: Predicted colon cancer genes by two methods (Naïve Bayes and Decision tree) 
on two groups of genes (48 random genes and 147 NCI colon cancer related genes). 
 
 
 
Table 5.4: Common predicted colon cancer genes by two methods (Naïve bayes and 
Decision tree) on 48 random genes and 147 NCI colon cancer related genes.  
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Table 5.5: Annotation of common colon cancer genes predicted by Naïve Bayes and 
Decision tree on 48 random genes and 147 NCI colon cancer related genes. * refer to the 
predicted colon cancer gene from 48 random genes, the other predicted colon cancer 
genes are all predicted from 147 NCI colon cancer related genes. 
 
Gene 
symbol 
 
Gene name  Description 
GON4L* 
 
gon-4-like  
(C. elegans)  
 
PLA2G10 
 
Phospholipase  
A2, group X 
 
 
PMP22 
 
Peripheral myelin 
protein 22 
 
This gene encodes an integral membrane protein 
that is a major component of myelin in the 
peripheral nervous system 
 
SNAI1 
 
snail homolog 1 
(Drosophila) 
The Drosophila embryonic protein snail is a zinc 
finger transcriptional repressor which 
downregulates the expression of ectodermal genes 
within the mesoderm. The nuclear protein encoded 
by this gene is structurally similar to the Drosophila 
snail protein, and is also thought to be critical for 
mesoderm formation in the developing embryo. At 
least two variants of a similar processed 
pseudogene have been found on chromosome 2 
PLAA 
 
phospholipase A2-
activating protein 
 
 
ELF3 
 
E74-like factor 3  
 
 
HTT 
 
huntingtin 
 
Huntingtin is a disease gene linked to Huntington's 
disease, a neurodegenerative disorder characterized 
by loss of striatal neurons. This is thought to be 
caused by an expanded, unstable trinucleotide 
repeat in the huntingtin gene, which translates as a 
polyglutamine repeat in the protein product.  
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MIF 
 
macrophage 
migration 
inhibitory factor 
(glycosylation-
inhibiting factor) 
 
This gene encodes a lymphokine involved in cell-
mediated immunity, immunoregulation, and 
inflammation. It plays a role in the regulation of 
macrophage function in host defense through the 
suppression of anti-inflammatory effects of 
glucocorticoids. This lymphokine and the JAB1 
protein form a complex in the cytosol near the 
peripheral plasma membrane, which may indicate 
an additional role in integrin signaling pathways. 
 
GDF15 
 
Growth 
differentiation 
factor 15 
 
Bone morphogenetic proteins (e.g., BMP5; MIM 
112265) are members of the transforming growth 
factor-beta (see TGFB1; MIM 190180) superfamily 
and regulate tissue differentiation and maintenance. 
They are synthesized as precursor molecules that 
are processed at a dibasic cleavage site to release C-
terminal domains containing a characteristic motif 
of 7 conserved cysteines in the mature protein. 
 
LRP12 
 
low density 
lipoprotein-related 
protein 12 
 
This gene was identified by its differential 
expression in cancer cells. The product of this gene 
is predicted to be a transmembrane protein. The 
level of this protein was found to be lower in tumor 
derived cell lines compared to normal cells. This 
gene was thus proposed to be a candidate tumor 
suppressor gene. 
 
HSPB8 
 
heat shock 22kDa 
protein 8 
 
 
 
To search for the candidate colon cancer genes, we compared the genes on the 4 features 
used in prediction, plus an additional 7 features (see chapter 4) that we used in this study: 
(1) average number of Alu elements per gene; (2) average number of AluY subfamily 
element per gene; (3) average number of AluJ subfamily element per gene; (4) average 
number of AluS subfamily element per gene; (5) average distance from the nearest Alu 
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element to TSS per gene; (6) average number of CpG islands per gene; (7) average 
number of paired TFBS flanking CpG island within 50bp per gene. 
  
We have identified LRP2 as a good candidate for colon cancer gene.  First, the number of 
CpG island in LRP2 gene is as high as 4, consistent with the hypothesis: being more 
substrate for methylation enzyme.  Secondly, the sequence conservation of paired TFBS 
flanking CpG island within 50 base pairs is relatively low in LRP2, compared to the 
mean sequence conservation of paired TFBS in 24 colon cancer genes, which is also 
consistent with our hypothesis: lower sequence conservation could decrease the 
protection ability of TFBS to CpG island.  Third, from RefSeq, LRP2 is referred as a 
tumor suppressor gene because the level of LRP2 coded protein is found to be lower in 
tumor derived cell lines compared to normal cells (Table 5.5). 
 
Gene Ontology 
 
Our results suggest that for 24 colon cancer genes, the top three biological process in 
which colon cancer genes are involved are cell surface receptor linked signal 
transduction, regulation of cellular metabolic process and organ development (Table 5.6).  
For predicted colon cancer genes from 48 random genes by Naïve Bayes method, the top 
three biological processes are phosphate metabolic process, cellular protein metabolic 
process and regulation of cellular metabolic process (Table 5.7); the colon cancer genes 
predicted by Decision tree method are involved in cellular protein metabolic process, cell 
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development and phosphate metabolic process (Table 5.9).  For predicted non-colon 
cancer genes from 48 random genes by Naïve Bayes method, the top three biological 
processes are RNA metabolic process, cellular protein metabolic process and 
transcription (Table 5.7); the non-colon cancer genes predicted by Decision tree are 
involved in G1 Biopolymer metabolic process, protein metabolic process and signal 
transduction (Table 5.9).  For predicted colon cancer genes from 147 NCI colon cancer 
genes by Naïve Bayes method, the top three biological processes are cellular lipid 
metabolic process, inflammatory response and cell surface receptor linked signal 
transduction (Table 5.8); for predicted non-colon cancer genes from 147 NCI colon 
cancer genes by Naïve Bayes method, the top three biological processes are cellular 
protein metabolic process, regulation of cellular metabolic process and RNA metabolic 
process (Table 5.8).  For predicted colon cancer genes from 147 NCI colon cancer genes 
by Decision Tree method, the top three biological processes are cellular protein metabolic 
process, cell development, regulation of cellular metabolic process (Table 5.10); For 
predicted non-colon cancer genes from 147 NCI colon cancer genes by Decision Tree 
method, the top three biological processes are cellular protein metabolic protein, cell 
development and regulation of cellular metabolic process (Table 5.10).  
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Table 5.6: Annotation of 24 colon cancer genes on biological process.  
 
 
 
Table 5.7: Annotation of predicted colon cancer genes and non-colon cancer genes by 
Naïve Bayes method from 48 random genes. 
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Table 5.8: Annotation of predicted colon cancer genes and non-colon cancer genes by 
Naïve Bayes from 147 NCI colon cancer related genes. 
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Table 5.9: Annotation of predicted colon cancer genes and non-colon cancer genes by 
Decision tree method from 48 random genes. 
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Table 5.10: Annotation of predicted colon cancer genes and non-colon cancer genes by 
Decision tree from 147 NCI colon cancer related genes. 
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CHAPTER 6: DISCUSSION AND CONCLUSIONS 
 
Alu sequence study 
 
Alu subfamily distribution 
 
Previous studies indicate that the younger the Alu subfamily is the higher rate of 
methylation in the Alu sequences [18].  Our findings suggest that the proportion of AluY 
subfamily of colon cancer genes is lower than other groups of genes.  On the surface this 
would suggest that overall methylation in the Alu elements of colon cancer genes is lower 
than other genes. Experimental verification will be critical to determine if this is the case. 
 
Alu elements serve as de novo methylation center 
 
Our results suggest that the average Alu density in colon cancer genes is lower than in 
other groups of genes.  The significance of this is unclear at this time.  The average 
distance between the nearest Alu element to the transcription start site in colon cancer 
genes is shorter than in other groups of genes. We postulate if Alu sequence is the de 
novo methylation center of a promoter, the closer the Alu element is to the transcription 
start site, the easier its methylation could be expanded to the nearby CpG islands, 
affecting the transcription initiation.  It is conceivable that during colon tumor genesis, 
the CpG islands near the transcription start site of the colon tumor suppressor genes are 
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prone to become methylated, leading to inhibition of transcription and the subsequent 
development of cancers. 
 
CpG island methylation study 
 
Sp1 protection model 
 
One interesting hypothesis to account for the differential pattern of DNA methylation,  
conjectured by some researchers is that Alu sequences can be regarded as the de novo 
methylation centers because of their high methylation status and the transcription factor 
binding sites (TFBSs) flanking the CpG islands behave as boundaries to impede the 
methylation spreading from the methylation centers [31].  Our results show that it is 
common to identify a pair of TFBSs flanking the CpG islands in all of the five groups of 
genes (Appendix table 4).  This observation suggests that TFBSs cannot be the sole factor 
for protection from methylation.  Our results show that the average sequence 
conservation of these paired TFBS flanking CpG islands in colon cancer genes is lower 
than in Yamada unmethylated genes and random genes.  It is tempting to speculate that 
low degree of sequence conservation in TFBS might decrease the binding ability of 
transcription factors, hence leads to a lower degree of protection from methylation by 
TFBS.  
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CpG and TpG 
 
Our results show that the percentage of CpG dinucleotides in the promoter region of 
colon cancer genes is higher than in random genes with a significant difference (Figure 
4.6), but the percentage of TpG dinucleotides is lower than in random genes with 
significant difference (Figure 4.7).  It is currently unknown why this is so.  However, it 
would be consistent with the hypothesis that when the CpG dinucleotides in the 
promoters of colon cancer genes are at the non-diseased condition they are usually 
unmethylated. 
 
Feature selection and classification 
 
Our results imply that decision tree method in general perform better or at least as well as 
NaiveBayes method (Table 5.4).  However, our training data was limited to a very small 
set of genes.  It is unclear whether the performance of the two methods would be 
consistently the same for a larger data in the future.  
 
Future work 
 
Using the common genes predicted by two classifiers, we identified LRP12 as a 
candidate gene for colon cancers.  Experimentation on the methylation status of the 
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promoter and functional characterization of LRP12 in both normal cells and colon cancer 
cells are pressing. 
 
Work in the future should also include identification of more features which could 
separate colon cancer genes from normal genes.  In addition, different classification 
methods should be compared. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56
APPENDICES 
 
Appendix table 1: Annotation for 24 colon cancer genes.  
Gene symbol Gene name Description 
TAC1 tachykinin, 
precursor 1 
These encoded hormones are thought to function 
as neurotransmitters which interact with nerve 
receptors and smooth muscle cells. 
TBXA2R thromboxane A2 
receptor 
 
PTGS2 prostaglandin-
endoperoxide 
synthase 2 
PTGS, known as cyclooxygenase, is the key 
enzyme in prostaglandin biosynthesis, and acts 
both as a dioxygenase and as a peroxidase. 
MLH1 mutL homolog 1, 
colon cancer, 
nonpolyposis type 
2  
This gene was identified as a locus frequently 
mutated in hereditary nonpolyposis colon cancer 
(HNPCC). 
RARB retinoic acid 
receptor, beta 
It is thought that this protein limits growth of many 
cell types by regulating gene expression. 
FAT FAT tumor 
suppressor 
homolog 1 
This gene encodes a tumor suppressor essential for 
controlling cell proliferation during Drosophila 
development. 
SFRP1 secreted frizzled-
related protein 1 
It is involved in determining the polarity of 
photoreceptor cells in the retina. 
ENG Endoglin Endoglin is a component of the transforming 
growth factor beta receptor complex as it binds 
TGFB1 and TGFB3 with high affinity. 
DKK1 dickkopf 
homolog 1 
It is a secreted protein with two cysteine rich 
regions and is involved in embryonic development 
through its inhibition of the WNT signaling 
pathway.  
CALCA calcitonin-related 
polypeptide alpha 
Calcitonin causes reduction in serum calcium, an 
effect opposite to that of parathyroid hormone 
RBP1 Retinol binding 
protein 1, cellular 
RBP1 is the carrier protein involved in the 
transport of retinol (vitamin A alcohol) from the 
liver storage site to peripheral tissue. 
STK11 Serine/threonine 
kinase 11 
This gene, which encodes a member of the 
serine/threonine kinase family, regulates cell 
polarity and functions as a tumor suppressor. 
GATA5 GATA binding The protein encoded by this gene is a transcription 
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protein 5 factor that contains two GATA-type zinc fingers.  
AKAP12 A kinase (PRKA) 
anchor protein 
(gravin) 12 
The encoded protein is a cell growth-related 
protein. 
EPHB2 EPH receptor B2 Ephrin receptors and their ligands, the ephrins, 
mediate numerous developmental processes, 
particularly in the nervous system. 
GATA4 GATA binding 
protein 4 
The encoded protein is thought to regulate genes 
involved in embryogenesis and in myocardial 
differentiation and function. 
LMX1B LIM homeobox 
transcription 
factor 1, beta 
 
TMEFF2 transmembrane 
protein with EGF-
like and two 
follistatin-like 
domains 2 
 
CDKN2A cyclin-dependent 
kinase inhibitor 
2A 
This ARF product functions as a stabilizer of the 
tumor suppressor protein p53 as it can interact 
with, and sequester, MDM1, a protein responsible 
for the degradation of p53. 
WIF1 WNT inhibitory 
factor 1 
WNT proteins are extracellular signaling 
molecules involved in the control of embryonic 
development. 
SST Somatostatin The encoded hormone is an important regulator of 
the endocrine system through its interactions with 
pituitary growth hormone, thyroid stimulating 
hormone, and most hormones of the 
gastrointestinal tract. 
WRN Werner syndrome This gene encodes a member of the RecQ 
subfamily and the DEAH (Asp-Glu-Ala-His) 
subfamily of DNA and RNA helicases. DNA 
helicases are involved in many aspects of DNA 
metabolism, including transcription, replication, 
recombination, and repair. 
NELL NEL-like 1 This gene encodes a cytoplasmic protein that 
contains epidermal growth factor (EGF) -like 
repeats. 
MAL mal, T-cell 
differentiation 
protein 
The encoded protein has been localized to the 
endoplasmic reticulum of T-cells and is a 
candidate linker protein in T-cell signal 
transduction. 
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Appendix table 2: Annotation of 147 NCI colon cancer related genes 
(available  at 
http://www.chenlab.clemson.edu/staticpages/index.php?page=Datadownload) 
 
Appendix table 3: Annotation of 48 random genes  
(available at 
http://www.chenlab.clemson.edu/staticpages/index.php?page=Datadownload) 
 
Appendix table 4: Comparison of TFBS in protection model in five groups 
of genes  
(available at 
http://www.chenlab.clemson.edu/staticpages/index.php?page=Datadownload) 
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